The Business Research Company’s Antiparasitic Drugs Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Antiparasitic Drugs Global Market Report 2023 evaluates antiparasitic drugs market size, growth rate, drivers, trends, and major companies.
The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12927&type=smp
The global antiparasitic drugs market is expected to grow from $22.47 billion in 2023 to $24.06 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to prevalence of parasitic infections, resistance to existing treatments, global health initiatives,he antiparasitic drugs market size is expected to see strong growth in the next few years. It will grow to $31.19 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%.
The increasing incidence of vector-borne diseases is expected to propel the growth of the antiparasitic drugs market going forward. Vector-borne diseases refer to infectious diseases transmitted to humans or other animals through the bite of arthropods, primarily insects like mosquitoes, ticks and flies. Some examples of vector-borne diseases include malaria, dengue and yellow fever. Antiparasitic drugs play an essential role in stopping the spread of vector-borne diseases by targeting and eliminating the parasites responsible. A few antiparasitic drugs, including chloroquine, doxycycline and atovaquone-proguanil, are commonly used to cure malaria. For instance, in August 2023, according to the Pan American Health Organization, a US-based specialized agency of the United Nations, dengue incidences had significantly increased in the US so far in 2023. More than 3 million new infections have been reported so far, exceeding the numbers for 2019—the year with the most significant recorded incidence of the disease in the area, with 3.1 million cases, including 28,203 severe cases and 1,823 deaths. Furthermore, in December 2022, according to the World Malaria Report 2022 published by the World Health Organization, a Switzerland-based intergovernmental organization, 247 million malaria cases were recorded worldwide in 2021, up from 245 million cases in 2020. Therefore, the increasing incidence of vector-borne diseases drives the growth of the antiparasitic drugs market.
Get More Information On The Antiparasitic Drugs Market Report:
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report
The antiparasitic drugs market segments in the report are:
1) By Product Type: Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products
2) By Treatment: Avermectins, Bezimidazoles, Pyrimidines, Organophosphates, Imidazolesthiazoles
3) By Route of Administration: Oral, Injectable, Topical
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
The table of contents in TBRC’s antiparasitic drugs market report includes:
- Executive Summary
- Antiparasitic Drugs Market Characteristics
- Antiparasitic Drugs Market Trends And Strategies
- Antiparasitic Drugs Market – Macro Economic Scenario
- Global Antiparasitic Drugs Market Size and Growth
.
.
.
- Global Antiparasitic Drugs Market Competitive Benchmarking
- Global Antiparasitic Drugs Market Competitive Dashboard
- Key Mergers And Acquisitions In The Antiparasitic Drugs Market
- Antiparasitic Drugs Market Future Outlook and Potential Analysis
- Appendix
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
